Adipokine Adissp as a potential therapeutic agent for diabetes and cardiometabolic diseases
Ontology highlight
ABSTRACT: Adipokine Adissp simultaneously promotes glucose disposal and energy expenditure in adipose tissue. Treatment with recombinant Adissp (rAdissp) protein normalizes hyperglycemia and provides pleiotropic cardiometabolic benefits in diabetic and obese mice, primarily through its actions in white adipose tissue. RNA-seq analysis of inguinal white fat reveals that rAdissp activates a comprehensive thermogenic program characterized by enhanced mitochondrial metabolism, Ucp1-mediated uncoupling, glycolysis, and fatty acid futile cycling.
ORGANISM(S): Mus musculus
PROVIDER: GSE302416 | GEO | 2026/03/16
REPOSITORIES: GEO
ACCESS DATA